117 related articles for article (PubMed ID: 7677997)
21. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by 3'-blocked oligonucleotide primers.
Austermann S; Kruhøffer M; Grosse F
Biochem Pharmacol; 1992 Jun; 43(12):2581-9. PubMed ID: 1378738
[TBL] [Abstract][Full Text] [Related]
22. The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase.
Althaus IW; Gonzales AJ; Chou JJ; Romero DL; Deibel MR; Chou KC; Kezdy FJ; Resnick L; Busso ME; So AG
J Biol Chem; 1993 Jul; 268(20):14875-80. PubMed ID: 7686907
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
Sardana VV; Emini EA; Gotlib L; Graham DJ; Lineberger DW; Long WJ; Schlabach AJ; Wolfgang JA; Condra JH
J Biol Chem; 1992 Sep; 267(25):17526-30. PubMed ID: 1381350
[TBL] [Abstract][Full Text] [Related]
24. Mechanism and fidelity of HIV reverse transcriptase.
Kati WM; Johnson KA; Jerva LF; Anderson KS
J Biol Chem; 1992 Dec; 267(36):25988-97. PubMed ID: 1281479
[TBL] [Abstract][Full Text] [Related]
25. The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template.
Ma QF; Bathurst IC; Barr PJ; Kenyon GL
Biochemistry; 1992 Feb; 31(5):1375-9. PubMed ID: 1371070
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the RNA-directed DNA polymerase activity of a recombinant HIV-1 p51 reverse transcriptase by a p15 ribonuclease H domain.
Evans DB; Kézdy FJ; Tarpley G; Sharma SK
Biotechnol Appl Biochem; 1993 Feb; 17(1):91-102. PubMed ID: 7679907
[TBL] [Abstract][Full Text] [Related]
27. High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus.
Schneider DJ; Feigon J; Hostomsky Z; Gold L
Biochemistry; 1995 Jul; 34(29):9599-610. PubMed ID: 7542922
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 1. Phthalimidoalkyl and -alkylamino analogues.
Hoffman JM; Wai JS; Thomas CM; Levin RB; O'Brien JA; Goldman ME
J Med Chem; 1992 Oct; 35(21):3784-91. PubMed ID: 1279172
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of resistance to U-90152S and sensitization to L-697,661 by a proline to leucine change at residue 236 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
Fan N; Evans DB; Rank KB; Thomas RC; Tarpley WG; Sharma SK
FEBS Lett; 1995 Feb; 359(2-3):233-8. PubMed ID: 7532595
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous mutations at Tyr-181 and Tyr-188 in HIV-1 reverse transcriptase prevents inhibition of RNA-dependent DNA polymerase activity by the bisheteroarylpiperazine (BHAP) U-90152s.
Fan N; Rank KB; Evans DB; Thomas RC; Tarpley WG; Sharma SK
FEBS Lett; 1995 Aug; 370(1-2):59-62. PubMed ID: 7544302
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC
Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of HIV-1 reverse transcriptase. Termination of processive synthesis on a natural DNA template is influenced by the sequence of the template-primer stem.
Abbotts J; Bebenek K; Kunkel TA; Wilson SH
J Biol Chem; 1993 May; 268(14):10312-23. PubMed ID: 7683674
[TBL] [Abstract][Full Text] [Related]
33. Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template.
Kopp EB; Miglietta JJ; Shrutkowski AG; Shih CK; Grob PM; Skoog MT
Nucleic Acids Res; 1991 Jun; 19(11):3035-9. PubMed ID: 1711678
[TBL] [Abstract][Full Text] [Related]
34. L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro.
Goldman ME; O'Brien JA; Ruffing TL; Nunberg JH; Schleif WA; Quintero JC; Siegl PK; Hoffman JM; Smith AM; Emini EA
Antimicrob Agents Chemother; 1992 May; 36(5):1019-23. PubMed ID: 1380788
[TBL] [Abstract][Full Text] [Related]
35. Phosphorodithioate DNA as a potential therapeutic drug.
Marshall WS; Caruthers MH
Science; 1993 Mar; 259(5101):1564-70. PubMed ID: 7681216
[TBL] [Abstract][Full Text] [Related]
36. Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.
Shao X; Rytting AS; Ekstrand DH; Vrang L; Källander CF; Gronowitz JS
Antivir Chem Chemother; 1998 Mar; 9(2):167-76. PubMed ID: 9875388
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices.
Balani SK; Pitzenberger SM; Kauffman LR; Arison BH; Ramjit HG; Goldman ME; O'Brien JA; King JD; Hoffman JM; Rooney CS
Drug Metab Dispos; 1992; 20(6):869-76. PubMed ID: 1283569
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
Balani SK; Kauffman LR; Arison BH; Olah TV; Goldman ME; Varga SL; O'Brien JA; Ramjit HG; Rooney CS; Hoffman JM
Drug Metab Dispos; 1994; 22(2):200-5. PubMed ID: 7516852
[TBL] [Abstract][Full Text] [Related]
39. A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.
Dueweke TJ; Pushkarskaya T; Poppe SM; Swaney SM; Zhao JQ; Chen IS; Stevenson M; Tarpley WG
Proc Natl Acad Sci U S A; 1993 May; 90(10):4713-7. PubMed ID: 7685109
[TBL] [Abstract][Full Text] [Related]
40. Effect of a thiobenzimidazolone derivative on DNA strand transfer catalyzed by HIV-1 reverse transcriptase.
Gopalakrishnan V; Benkovic S
J Biol Chem; 1994 Feb; 269(6):4110-5. PubMed ID: 7508439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
